UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Reduction in parathyroid adenomas by cinacalcet therapy in patients with primary hyperparathyroidism

Journal of bone and mineral metabolism, 2021-07, Vol.39 (4), p.583-588

2021

Volltextzugriff (PDF)

Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma

Endocrine Journal, 2019, Vol.66(2), pp.187-192

2019

Volltextzugriff (PDF)

Adrenal Hemorrhage in a Cortisol-Secreting Adenoma Caused by Antiphospholipid Syndrome Revealed by Clinical and Pathological Investigations: A Case Report

Frontiers in endocrinology (Lausanne), 2022-02, Vol.12, p.769450

2022

Volltextzugriff (PDF)

Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome

Internal Medicine, 2018/09/01, Vol.57(17), pp.2467-2472

2018

Volltextzugriff (PDF)

Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitus

Drug Discoveries & Therapeutics, 2019/12/31, Vol.13(6), pp.322-327

2019

Volltextzugriff (PDF)

Inhibition of NR5A1 Phosphorylation Alleviates a Transcriptional Suppression Defect Caused by a Novel NR0B1 Mutation

Journal of the Endocrine Society, 2022-06, Vol.6 (6), p.bvac068-bvac068

2022

Volltextzugriff (PDF)

Serum γ-glutamyltransferase, triglyceride and total cholesterol are possible prediabetic risk markers in young Japanese men

Endocrine Journal, 2010, Vol.57(11), pp.981-989

2010

Volltextzugriff (PDF)

Clinical investigation of a unique type of hypothalamic adrenal insufficiency

Medicine (Baltimore), 2022-10, Vol.101 (41), p.e30597-e30597

2022

Volltextzugriff (PDF)

Investigation of the metabolic and endocrinological differences between daily and weekly growth hormone replacement therapy, somapacitan, in patients with adult growth hormone deficiency: A real-world pilot study

Medicine (Baltimore), 2023-09, Vol.102 (38), p.e34730-e34730

2023

Volltextzugriff (PDF)

Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: Effect of denosumab on glycemic parameters

Medicine (Baltimore), 2019-11, Vol.98 (47), p.e18067

2019

Volltextzugriff (PDF)

Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas

Medicine (Baltimore), 2022-12, Vol.101 (50), p.e32026-e32026

2022

Volltextzugriff (PDF)

Clinical investigation of pituitary incidentalomas: A two-center study

Intractable & Rare Diseases Research, 2019/11/30, Vol.8(4), pp.239-244

2019

Volltextzugriff (PDF)

Contributing factors related to efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes

Diabetes research and clinical practice, 2012-02, Vol.95 (2), p.e27-e28

2012

Volltextzugriff (PDF)

Comprehensive Efficacy of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin in Practical Clinical Settings: A Prospective Multi-Center Interventional Observational Study

Journal of clinical medicine research, 2020-07, Vol.12 (7), p.423-430

2020

Volltextzugriff (PDF)

Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma

ENDOCRINE JOURNAL, 2019, Vol.66 (2), p.187-192

2019

Volltextzugriff (PDF)

Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma

Endocrine Journal, 2019, pp.EJ18-0407

2019

Volltextzugriff (PDF)

Multicenter prospective observational study of teneligliptin, a selective dipeptidyl peptidase-4 inhibitor, in patients with poorly controlled type 2 diabetes: Focus on glycemic control, hypotensive effect, and safety Chikushi Anti-Diabetes Mellitus Trial-Teneligliptin (CHAT-T)

Clinical and experimental hypertension (1993), 2020-04, Vol.42 (3), p.197-204

2020

Volltextzugriff (PDF)

Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis

Diabetology and metabolic syndrome, 2015-05, Vol.7 (1), p.44-44, Article 44

2015

Volltextzugriff (PDF)

Two Cases of Mitochondrial Diabetes in Which Pancreatic Beta-Cell Function and Neuropathy Were Improved by Glucagon-Like Peptide-1 Receptor Agonist Therapy

Journal of endocrinology and metabolism, 2019-04, Vol.9 (1-2), p.33-36

2019

Volltextzugriff (PDF)

A Case of Autoimmune Polyglandular Syndrome Type 3 Which Developed Chronic Thyroiditis, Autoimmune Hepatitis, Slowly Progressive Type 1 Diabetes Mellitus and Systemic Lupus Erythematosus Through 16-Year Duration

Journal of the Japan Diabetes Society, 2016/03/30, Vol.59(3), pp.163-173

2016

Volltextzugriff (PDF)

Bone and Men's Health. The role of androgens in bone metabolism

Clinical calcium, 2010-02, Vol.20 (2), p.165

2010

Volltextzugriff (PDF)

Cortisol, cortisone, urinary free cortisol

Nihon rinshō, 2010-07, Vol.68 Suppl 7, p.331

2010

Volltextzugriff (PDF)

Serum γ-glutamyltransferase, triglyceride and total cholesterol are possible prediabetic risk markers in young Japanese men

ENDOCRINE JOURNAL, 2010, Vol.57 (11), p.981-989

2010

Volltextzugriff (PDF)

P1-3-7 Serum γ-glutamyltransferase and triglyceride are prediabetic risk markers in young Japanese men with normal glucose tolerance

ENDOCRINE JOURNAL, 2010, Vol.57 (suppl.2-1), p.S360-S360

2010

Volltextzugriff (PDF)

16年間に慢性甲状腺炎・自己免疫性肝炎・緩徐進行1型糖尿病・全身性エリテマトーデスを発症した1例

糖尿病, 2016/03/30, Vol.59(3), pp.163-173

2016

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)
Berichte
(1)

Sprache

Englisch
(21)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Humans
(9)
Endocrinology & Metabolism
(7)
General & Internal Medicine
(6)
Medicine, General & Internal
(6)
Female
(5)
Male
(5)
Observational Study
(4)
Aged
(3)
Diabetes Mellitus, Type 2 - Drug Therapy
(3)
Hormonal Deficiency
(3)
Insulin Resistance
(3)
Original
(3)
Pheochromocytoma
(3)
Pituitary Apoplexy
(3)
Pituitary Incidentaloma
(3)
Type 2 Diabetes
(3)
Adenoma - Complications
(2)
Adult
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Reduction in parathyroid adenomas by cinacalcet therapy in patients with primary hyperparathyroidism

Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma

Adrenal Hemorrhage in a Cortisol-Secreting Adenoma Caused by Antiphospholipid Syndrome Revealed by Clinical and Pathological Investigations: A Case Report

Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome

Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitus

Inhibition of NR5A1 Phosphorylation Alleviates a Transcriptional Suppression Defect Caused by a Novel NR0B1 Mutation

Serum γ-glutamyltransferase, triglyceride and total cholesterol are possible prediabetic risk markers in young Japanese men

Clinical investigation of a unique type of hypothalamic adrenal insufficiency

Investigation of the metabolic and endocrinological differences between daily and weekly growth hormone replacement therapy, somapacitan, in patients with adult growth hormone deficiency: A real-world pilot study

Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: Effect of denosumab on glycemic parameters

Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas

Clinical investigation of pituitary incidentalomas: A two-center study

Contributing factors related to efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes

Comprehensive Efficacy of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin in Practical Clinical Settings: A Prospective Multi-Center Interventional Observational Study

Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma

Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma

Multicenter prospective observational study of teneligliptin, a selective dipeptidyl peptidase-4 inhibitor, in patients with poorly controlled type 2 diabetes: Focus on glycemic control, hypotensive effect, and safety Chikushi Anti-Diabetes Mellitus Trial-Teneligliptin (CHAT-T)

Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis

Two Cases of Mitochondrial Diabetes in Which Pancreatic Beta-Cell Function and Neuropathy Were Improved by Glucagon-Like Peptide-1 Receptor Agonist Therapy

A Case of Autoimmune Polyglandular Syndrome Type 3 Which Developed Chronic Thyroiditis, Autoimmune Hepatitis, Slowly Progressive Type 1 Diabetes Mellitus and Systemic Lupus Erythematosus Through 16-Year Duration

Bone and Men's Health. The role of androgens in bone metabolism

Cortisol, cortisone, urinary free cortisol

Serum γ-glutamyltransferase, triglyceride and total cholesterol are possible prediabetic risk markers in young Japanese men

P1-3-7 Serum γ-glutamyltransferase and triglyceride are prediabetic risk markers in young Japanese men with normal glucose tolerance

16年間に慢性甲状腺炎・自己免疫性肝炎・緩徐進行1型糖尿病・全身性エリテマトーデスを発症した1例

Suchergebnisse filtern